Pfizer Pharmaceuticals Ltd.: clinical-trial pipeline
Pfizer Pharmaceuticals Ltd. is the sponsor of 3,301 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 241 are not yet finished and 24 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials241
Phase 2/3 and 3674
Countries100
New in 90 days24
Trials by phase
| Phase | Trials |
|---|---|
| Phase 1 | 1,117 |
| Phase 3 | 634 |
| Not applicable | 620 |
| Phase 2 | 602 |
| Phase 4 | 220 |
| Phase 1/2 | 66 |
| Phase 2/3 | 40 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 2,504 |
| Terminated | 455 |
| Recruiting | 110 |
| Withdrawn or not authorised | 101 |
| Active, not recruiting | 97 |
| Not yet recruiting | 34 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 711 |
| Infectious disease and vaccines | 436 |
| Immunology and rheumatology | 394 |
| Nephrology and urology | 242 |
| Metabolic and endocrine (diabetes, obesity) | 219 |
| Dermatology | 187 |
| Neurology | 186 |
| Cardiovascular | 183 |
| Gastroenterology and liver | 173 |
| Respiratory | 146 |
| Haematology | 107 |
| Rare and genetic diseases | 100 |
Countries
| Country | Trials |
|---|---|
| United States | 1,887 |
| Canada | 503 |
| Spain | 501 |
| Belgium | 488 |
| Germany | 444 |
| United Kingdom | 408 |
| Japan | 405 |
| Poland | 369 |
| France | 366 |
| Italy | 365 |
| Australia | 330 |
| South Korea | 327 |
| Czechia | 247 |
| Hungary | 239 |
| China | 230 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-22 | New trial posted | A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Parti… |
| 2026-10-21 | New trial posted | A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults |
| 2026-10-21 | New trial posted | A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermat… |
| 2026-10-19 | New trial posted | A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Mult… |
| 2026-10-19 | New trial posted | A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults Wi… |
| 2026-10-15 | New trial posted | A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Toler… |
| 2026-10-15 | New trial posted | A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken u… |
| 2026-10-15 | New trial posted | A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared… |
| 2026-10-09 | New trial posted | A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With… |
| 2026-10-05 | New trial posted | A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia… |
| 2026-09-29 | New trial posted | A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese… |
| 2026-09-29 | New trial posted | A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-0865… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06072183 | A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranq… | Phase 3 | Active, not recruiting | Australia, Belgium, Bulgaria, Canada +13 |
| NCT05317416 | Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant | Phase 3 | Active, not recruiting | Austria, Australia, Belgium, Brazil +22 |
| NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metast… | Phase 3 | Active, not recruiting | Argentina, Australia, Belgium, Bulgaria +25 |
| NCT06206837 | A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast… | Phase 1/2 | Active, not recruiting | Belgium, Canada, China, Spain +4 |
| NCT06163326 | A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitil… | Phase 3 | Not yet recruiting | Australia, Bulgaria, Canada, China +9 |
| NCT06152575 | MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (… | Phase 3 | Recruiting | Argentina, Australia, Belgium, Brazil +23 |
| NCT05160922 | Crizotinib Continuation Clinical Study | Phase 4 | Recruiting | China, Italy, Japan, Russia +1 |
| NCT04657991 | A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Adva… | Phase 3 | Active, not recruiting | Argentina, Austria, Belgium, Bulgaria +22 |
| NCT05262400 | A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participant… | Phase 1/2 | Active, not recruiting | Argentina, Bulgaria, Brazil, China +5 |
| NCT04821622 | Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC | Phase 3 | Active, not recruiting | Argentina, Australia, Belgium, Bulgaria +22 |
| NCT04165317 | A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer | Phase 3 | Active, not recruiting | Australia, Belgium, Canada, China +10 |
| NCT04557449 | Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors | Phase 1/2 | Recruiting | Argentina, China, Czechia, United Kingdom +4 |
| NCT04370054 | Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Modera… | Phase 3 | Active, not recruiting | Australia, Brazil, Canada, Germany +11 |
| NCT03052608 | A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC | Phase 3 | Active, not recruiting | Argentina, Australia, Belgium, Canada +18 |
| NCT04743141 | Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine | Phase 3 | Recruiting | Spain, Poland, United States |
| NCT04624230 | Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerativ… | Phase 3 | Not yet recruiting | Australia, Belgium, Canada, Germany +13 |
| NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | Phase 3 | Recruiting | Canada, China, Spain, United Kingdom +5 |
| NCT04281485 | Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy | Phase 3 | Active, not recruiting | Australia, Belgium, Canada, Switzerland +11 |
| NCT06105632 | A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With H… | Phase 2 | Active, not recruiting | Argentina, Australia, Belgium, Bulgaria +23 |
| NCT05217446 | A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in Pe… | Phase 2 | Not yet recruiting | Australia, Belgium, Canada, Czechia +12 |
| NCT05431088 | A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD | Phase 2/3 | Not yet recruiting | Belgium, Brazil, Germany, Spain +9 |
| NCT05156398 | Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | Phase 3 | Recruiting | Canada, Spain, France, Italy +3 |
| NCT02319837 | Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMB… | Phase 3 | Active, not recruiting | Austria, Australia, Brazil, Canada +13 |
| NCT05623020 | A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared W… | Phase 3 | Recruiting | Austria, Australia, Belgium, Brazil +21 |
| NCT05995964 | A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Sever… | Phase 2 | Active, not recruiting | Australia, Canada, China, Germany +3 |
Hiring for clinical development
Pfizer Pharmaceuticals Ltd. has 65 open jobs with a clinical, regulatory, safety, biostatistics or medical-affairs title on its own career sites.
Website: pfizer.com. All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Pfizer Pharmaceuticals Ltd. clinical trials: 241 open, 674 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/pfizer-com/, data as of 2026-10-25.